Evoxac capsules 30 mg for dry mouth (Sjogren's syndrome, cevimeline, Saligren)

What are Evoxac capsules 30 mg for dry mouth (Sjogren's syndrome, cevimeline, Saligren)

The active principle of Evoxac capsules is cevimeline hydrochloride hydrate, a parasympathomimetic and muscarinic agonist. It works by activating certain receptors of the parasympathetic nervous system. Evoxac capsules stimulate secretion of the salivary glands and promote salivation. Studies showed that treatment with cevimeline hydrochloride within 52 weeks was very effective for increasing salivary flow and improving subjective and objective symptoms in patients with both Sjogren's syndrome and psychosomatic oral disease.

Active principles: cevimeline hydrochloride hydrate

Amount: 100 capsules

Maker: Daiichi Sankyo Co., Ltd., Tokyo, Japan

Indications: oral dryness in the patients with Sjogren's syndrome

How to take

Adults should take 1 capsule (30 mg of the active principle) 3 times a day after meals.

Contraindications: do not use for the following patients:

• pregnant and breastfeeding women,
• patients with ischemic heart disease (myocardial infarction, angina pectoris etc.),
• patients with bronchial asthma or chronic obstructive pulmonary disease,
• patients with gastrointestinal obstruction or urinary bladder neck obstruction,
• patients with epilepsy,
• patients with Parkinsonian syndrome or Parkinson's disease,
• patients with iritis.

Important information

As these tablets may cause miosis, patient should take special care when driving a car during the evening, or operating dangerous machinery in a dark place.

If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.